Literature DB >> 27315462

Twist1 and Slug mediate H2AX-regulated epithelial-mesenchymal transition in breast cells.

Urbain Weyemi1,2, Christophe E Redon1, Taresh K Sethi1, Allison S Burrell1, Parthav Jailwala3, Manjula Kasoji3, Natalie Abrams3, Anand Merchant3, William M Bonner1.   

Abstract

The epithelial-mesenchymal transition (EMT) is thought to be essential for cancer metastasis. While chromatin remodeling is involved in EMT, which processes contribute to this remodeling remain poorly investigated. Recently, we showed that silencing or removal of the histone variant H2A.X induced mesenchymal-like characteristics, including activation of the EMT transcription factors, Slug and Zeb1 in human colon cancer cells. Here, we provide the evidence that H2A.X loss in human non-tumorigenic breast cell line MCF10A results in a robust EMT activation, as substantiated by a genome-wide expression analysis. Cells deficient for H2A.X exhibit enhanced migration and invasion, along with an activation of a set of mesenchymal genes and a concomitant repression of epithelial genes. In the breast model, the EMT-related transcription factor Twist1 cooperates with Slug to regulate EMT upon H2A.X Loss. Of interest, H2A.X expression level tightly correlates with Twist1, and to a lesser extent with Slug in the panel of human breast cancer cell lines of the NCI-60 datasets. These new findings indicate that H2A.X is involved in the EMT processes in cells of different origins but pairing with transcription factors for EMT may be tissue specific.

Entities:  

Keywords:  EMT; Slug; Twist1; breast cancer; histone H2AX

Mesh:

Substances:

Year:  2016        PMID: 27315462      PMCID: PMC5026799          DOI: 10.1080/15384101.2016.1198864

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

Authors:  Luika A Timmerman; Joaquín Grego-Bessa; Angel Raya; Esther Bertrán; José María Pérez-Pomares; Juan Díez; Sergi Aranda; Sergio Palomo; Frank McCormick; Juan Carlos Izpisúa-Belmonte; José Luis de la Pompa
Journal:  Genes Dev       Date:  2003-12-30       Impact factor: 11.361

Review 2.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.

Authors:  Stefan Grünert; Martin Jechlinger; Hartmut Beug
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 5.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

7.  Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy.

Authors:  Christelle P El-Haibi; George W Bell; Jiangwen Zhang; Anthony Y Collmann; David Wood; Cally M Scherber; Eva Csizmadia; Odette Mariani; Cuihua Zhu; Antoine Campagne; Mehmet Toner; Sangeeta N Bhatia; Daniel Irimia; Anne Vincent-Salomon; Antoine E Karnoub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-02       Impact factor: 11.205

Review 8.  Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

Authors:  Dingcheng Gao; Linda T Vahdat; Stephen Wong; Jenny C Chang; Vivek Mittal
Journal:  Cancer Res       Date:  2012-09-20       Impact factor: 12.701

Review 9.  Oncogenic roles of EMT-inducing transcription factors.

Authors:  Alain Puisieux; Thomas Brabletz; Julie Caramel
Journal:  Nat Cell Biol       Date:  2014-06       Impact factor: 28.824

10.  Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.

Authors:  Spencer C Wei; Laurent Fattet; Jeff H Tsai; Yurong Guo; Vincent H Pai; Hannah E Majeski; Albert C Chen; Robert L Sah; Susan S Taylor; Adam J Engler; Jing Yang
Journal:  Nat Cell Biol       Date:  2015-04-20       Impact factor: 28.824

View more
  12 in total

Review 1.  Radiation therapy-induced metastasis: radiobiology and clinical implications.

Authors:  Benjamin J Blyth; Aidan J Cole; Michael P MacManus; Olga A Martin
Journal:  Clin Exp Metastasis       Date:  2017-11-20       Impact factor: 5.150

Review 2.  DNA double-strand break repair in cancer: A path to achieving precision medicine.

Authors:  Taneisha Gillyard; Jamaine Davis
Journal:  Int Rev Cell Mol Biol       Date:  2021-08-03       Impact factor: 6.813

3.  MicroRNA-610 suppresses osteosarcoma oncogenicity via targeting TWIST1 expression.

Authors:  Chi Jin; Yongjian Feng; Yongjian Ni; Zhonglin Shan
Journal:  Oncotarget       Date:  2017-04-11

4.  MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.

Authors:  Saber Imani; Chunli Wei; Jingliang Cheng; Md Asaduzzaman Khan; Shangyi Fu; Luquan Yang; Mousumi Tania; Xianqin Zhang; Xiuli Xiao; Xianning Zhang; Junjiang Fu
Journal:  Oncotarget       Date:  2017-03-28

Review 5.  Post-Translational Modifications of H2A Histone Variants and Their Role in Cancer.

Authors:  David Corujo; Marcus Buschbeck
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

6.  Genomic instability and mitochondrial homeostasis in cancer: does chromatin have a say?

Authors:  Yue Liu; Haojian Li; Susan E Zimmerman; Urbain Weyemi
Journal:  Mol Cell Oncol       Date:  2020-07-13

Review 7.  EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells.

Authors:  Eva Rodriguez-Aznar; Lisa Wiesmüller; Bruno Sainz; Patrick C Hermann
Journal:  Cancers (Basel)       Date:  2019-08-08       Impact factor: 6.639

8.  CDX2 inhibits epithelial-mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression.

Authors:  Junhui Yu; Shan Li; Zhengshui Xu; Jing Guo; Xiaopeng Li; Yunhua Wu; Jianbao Zheng; Xuejun Sun
Journal:  Br J Cancer       Date:  2020-11-26       Impact factor: 7.640

Review 9.  The Role of Histone Variants in the Epithelial-To-Mesenchymal Transition.

Authors:  Imtiaz Nisar Lone; Burcu Sengez; Ali Hamiche; Stefan Dimitrov; Hani Alotaibi
Journal:  Cells       Date:  2020-11-17       Impact factor: 6.600

10.  Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking.

Authors:  Joshua T Rose; Eliana Moskovitz; Joseph R Boyd; Jonathan A Gordon; Nicole A Bouffard; Andrew J Fritz; Anuradha Illendula; John H Bushweller; Jane B Lian; Janet L Stein; Sayyed K Zaidi; Gary S Stein
Journal:  Oncotarget       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.